Being a small, secretory glycoprotein [11], HE4 is readily detectable in plasma and the serum levels of HE4 are considered a potential biomarker for ovarian cancer diagnosis and management [13–16]. This evidence concerns the gene WFDC2 and ovarian carcinoma.